RaySearch releases new version of treatment planning system RayStation

World |  News | 0 Comment | 01 Jul, 2019

RaySearch has announced the release of RayStation® 9A*, the latest version of the innovative radiation therapy treatment planning system (TPS). RayStation 9A holds several improvements,...Read more

Pancreatic Cancer Action Network furthers research investment though funding of scientific grants

World |  News | 0 Comment | 01 Jul, 2019

The Pancreatic Cancer Action Network (PanCAN), dedicated to fighting the world's toughest cancer has announced the recipients of its 2019 research grants. Through a highly competitive ...Read more

Lou Kennedy named HealthCare Entrepreneur of the Year

World |  News | 0 Comment | 01 Jul, 2019

Ernst & Young (EY) honoured Nephron Pharmaceuticals President and CEO Lou Kennedy as Health Care Entrepreneur of the Year for the Southeast on Thursday during a gala...Read more

Khiron welcomes EU trade deal with Latin American countries

World |  News | 0 Comment | 01 Jul, 2019

Khiron Life Sciences Corp., a cannabis company with core operations in Latin America, applauds the EU-Mercosur Trade Agreement announced between the European Union and Mercosur, the La...Read more

Vaxess Technologies closes final tranche of $8.2 million Series A funding

World |  News | 0 Comment | 01 Jul, 2019

Vaxess Technologies, a biotechnology company redefining drug delivery with the silk-powered MIMIX smart release patch has announced it has closed the final tranche of an $8.2 million Series...Read more

New WHO Goodwill Ambassador for Universal Health Coverage

World |  News | 0 Comment | 02 Jul, 2019

WHO has announced the appointment of Professor Keizo Takemi as WHO Goodwill Ambassador for Universal Health Coverage. Professor Takemi is an internationally renowned advocate on global hea...Read more

Sartorius launches new ambr 250 vessel for cell, gene therapy applications

World |  News | 0 Comment | 28 Jun, 2019

Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical industry has recently launched a new vessel for its ambr® 250 modular benchtop au...Read more

CHMP recommends approval of Roche's Tecentriq in combination with Abraxane

World |  News | 0 Comment | 28 Jun, 2019

Roche has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq (atezolizumab)...Read more

Pfizer elects Scott Gottlieb to Board of Directors

World |  News | 0 Comment | 01 Jul, 2019

Pfizer has announced the election of Dr. Scott Gottlieb to its Board of Directors, effective immediately. Dr. Gottlieb, age 47, was also appointed to the Regulatory and Compliance Comm...Read more

J&J’s DARZALEX gets USFDA approval to treat multiple myeloma

World |  News | 0 Comment | 28 Jun, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) approval of DARZALEX® (daratumumab) in combination with lena...Read more

Thermo Fisher launches next-generation open air orbital shakers

World |  News | 0 Comment | 28 Jun, 2019

Thermo Fisher Scientific has developed a new line of next-generation open air orbital shakers to offer unmatched reliability and superior user programmability in a compact benchtop design. ...Read more

CarThera appoints Pascal E. R. Girin as chairman of board of directors

World |  News | 0 Comment | 28 Jun, 2019

CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces the appointment of Pascal E. R. Girin as chairman ...Read more

Concept Life Sciences Opens New Pharmaceutical Manufacturing Support Services

World |  News | 0 Comment | 28 Jun, 2019

Concept Life Sciences, a knowledge-based provider of integrated discovery, development and analytical services, on 18 June 2019, unveiled a new, state-of-the-art clinical and niche commerci...Read more

Abbvie to acquire Allergan in a deal worth $63B

World |  News | 0 Comment | 27 Jun, 2019

AbbVie and Allergan have announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction...Read more

FDA approves first treatment for chronic rhinosinusitis with nasal polyps

World |  News | 0 Comment | 27 Jun, 2019

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis ...Read more

NIH launches large TB prevention trial

World |  News | 0 Comment | 27 Jun, 2019

A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and eff...Read more

Medherant sets next clinical stage development by appointing John Burt as new CEO

World |  News | 0 Comment | 27 Jun, 2019

Medherant Limited, the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch®, has appointed John Bu...Read more

Cobra Biologics, Symbiosis complete £4.8M viral vector supply chain collaboration

World |  News | 0 Comment | 26 Jun, 2019

Cobra Biologics, an international contract development and manufacturing organisation (CDMO) focused on viral vector drug substance production, and Symbiosis Pharmaceutical Services (S...Read more